Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Cardiovascular Devices Market Research Report: Size, Growth, Trends and Forecast to 2035

Author: Rutuja Borkar
by Rutuja Borkar
Posted: Sep 23, 2026

Cardiovascular Devices Market growth

The global cardiovascular devices market was valued at USD 73.65 billion in 2025 and is projected to reach USD 152.81 billion by 2035, growing at a 7.6% CAGR from 2026 to 2035. Rising cardiovascular disease prevalence, population aging, and lifestyle-related risk factors are driving demand for advanced cardiac technologies.

Rising cardiovascular disease burden

Cardiovascular diseases caused approximately 19.8 million deaths in 2022, representing nearly 32% of global deaths, with more than 85% resulting from heart attacks and strokes. The growing burden of coronary artery disease, heart failure, and arrhythmias is increasing demand for stents, pacemakers, implantable defibrillators, heart valves, and cardiac imaging systems.

Minimally invasive procedures

The increasing adoption of minimally invasive cardiovascular procedures is accelerating market development. In the U.S., approximately 435,895 PCI procedures were performed in 2022, while TAVR procedures increased from 13,723 during 2011–2013 to 72,991 in 2019, highlighting growing adoption of catheter-based cardiac interventions.

Get a Free Sample: https://www.cervicornconsulting.com/sample/2986

Key market segments

Therapeutic & surgical devices held 67.4% of the market in 2025, while diagnostic and monitoring devices accounted for 32.6%. By application, coronary artery disease held 42.8%, followed by cardiac arrhythmia at 26.7%. Hospitals dominated end users with a 71.2% share.

North America leadership

North America dominated the cardiovascular devices market with a 39.8% share, supported by advanced healthcare infrastructure, favorable reimbursement policies, skilled specialists, and rapid adoption of innovative cardiac technologies. Strong demand for minimally invasive interventions, cardiac rhythm management, and AI-enabled diagnostics is supporting regional growth.

Asia-Pacific opportunity

Asia-Pacific is the fastest-growing regional market, driven by rising cardiovascular disease prevalence, aging populations, healthcare expenditure, improved insurance coverage, and expanding access to advanced cardiac care. Investments in hospitals, catheterization laboratories, digital healthcare, and local medical-device manufacturing are creating opportunities for cardiovascular device companies.

Technology innovation

Technological advances in AI-enabled cardiac imaging, transcatheter heart valves, drug-eluting stents, pulsed field ablation, remote cardiac monitoring, and next-generation implantable devices are transforming cardiovascular care. These technologies can support minimally invasive treatment, improve procedural precision, and reduce recovery time.

Market opportunities

Growing adoption of wearable ECG monitors, implantable cardiac monitors, AI-powered diagnostics, and remote patient monitoring is creating new opportunities beyond hospital-based care. Emerging markets across Asia-Pacific, Latin America, and the Middle East also offer opportunities as healthcare infrastructure, insurance coverage, and investment in advanced medical technologies expand.

Industry challenges

High costs, stringent regulatory requirements, shortages of skilled cardiovascular specialists, and cybersecurity risks remain important challenges. Connected pacemakers, implantable monitors, and remote monitoring systems transmit sensitive patient data, increasing the need for strong cybersecurity and data-protection measures.

Competitive innovation

Leading companies are advancing minimally invasive and technology-enabled cardiovascular treatments. Recent developments include Edwards Lifesciences' SAPIEN M3 TMVR System, Boston Scientific's FARAPULSE PFA System, Medtronic's PulseSelect PFA System, Abbott's TriClip TEER System, Meril Life Sciences' MyClip TEER System, and Stereotaxis' MAGiC Robotic Magnetic Ablation Catheter.

Explore market opportunities

With the market expected to more than double to USD 152.81 billion by 2035, cardiovascular device manufacturers, investors, healthcare providers, and technology companies can benefit from detailed insights into market segments, regional opportunities, competitive developments, and emerging technologies.

Explore the Cardiovascular Devices Market Report: https://www.cervicornconsulting.com/cardiovascular-devices-market

About the Author

Rutuja Borkar, Working in Cervicorn Consulting, a market research firm specializing in providing insightful analysis across various industries.

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Rutuja Borkar

Rutuja Borkar

Member since: Dec 26, 2024
Published articles: 15

Related Articles